PHARMGETH
ActiveSummary
PHARMGETH has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €668,073 and a net result of -€5,383. Equity is growing by about 3.4% per year across the filed financial years. Its solvency ranks better than 51% of 3,853 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
History
Acts, filings and financial milestones
21-05
Gazette deed
Reappointments: Filip VANSTEELANT (bestuurder, gedelegeerd bestuurder en voorzitter van de raad van bestuur) and Jocelyne LETERME (director)4 facts ▸
- General meeting, 02-12-2023
- Board meeting, 02-12-2023
- Director reappointment, Filip VANSTEELANT (bestuurder, gedelegeerd bestuurder en voorzitter van de raad van bestuur)
- Director reappointment, Jocelyne LETERME (director)
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.